Big Gain For Virax Biolabs Group Limited
Mon, Jul 25, 2022 at 07:00 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) rocketted at $16.8, a gain of 62.5%. On Mon, Jul 25, 2022, VRAX:NASDAQ hit a New 2-Week Intraday Low of $10.12. The stock got featured on our News Catalysts scanner on Fri, Jul 22, 2022 at 06:09 AM in the 'PUBLIC OFFERING' category. From Thu, Jul 21, 2022, the stock recorded 50.00% Up Days and 33.33% Green Days
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Redbox Entertainment Inc. (RDBX:NASDAQ), 81.97%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 62.48%
- Nano Labs Ltd (NA:NASDAQ), 55.52%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 45.38%
- Koss Corporation (KOSS:NASDAQ), 45.27%
- Infrastructure and Energy Alternatives, Inc. (IEA:NASDAQ), 31.83%
- FaZe Holdings Inc. (FAZE:NASDAQ), 29.65%
- NuCana plc (NCNA:NASDAQ), 29.36%
- OPAL Fuels Inc. (OPAL:NASDAQ), 28.75%
- Borr Drilling Limited (BORR:NYSE), 20.38%